Study details
Enrolling now
4-Aminopyridine Treatment for Nerve Injury
John Elfar
NCT IDNCT03701581ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
70
Study length
about 7.6 years
Ages
45–75
Sex
Male only
Locations
2 sites in AZ, NY
About this study
This trial is testing whether 4-aminopyridine (4-AP) can help with recovery after nerve injuries. The treatment will be compared to a placebo.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take 4-Aminopyridine
PhasePhase 2/Phase 3
Drug4-Aminopyridine
Primary goalMichigan Incontinence Sympton Index (M-ISI) (change over time)
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
fampridine
Endpoints
Primary: Michigan Incontinence Sympton Index (M-ISI) (change over time)
Body systems
Oncology